Déjà Vu: CBER Director’s Intervention Saves Sarepta’s Elevidys Again

 
• By Bridget Silverman
  
Boy in wheelchair
FDA expanded use of Elevidys to non-ambulatory DMD patients under accelerated approval. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews